Lipofabrik

Founded: 2013 • Age: 13 yrs Acquired By Groupe Elephant Vert
Manufactures bacillus species-based lipopeptides

About Lipofabrik

Lipofabrik is a company founded in 2013 was acquired by Groupe Elephant Vert in February 2022.. Lipofabrik operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Sectors
    Chemicals & Materials
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Chemicals & Materials → Industrial & Technical Services
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $1.78 M (USD), Grant

    Apr 01, 2019

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Groupe Elephant Vert

    (Feb 23, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Lipofabrik

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $1.8M
  • First Round

    (01 Jan 2018)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2019 Amount Grant - Lipofabrik Valuation

investors

Jan, 2018 Amount Grant - Lipofabrik Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Lipofabrik

Lipofabrik has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Groupe Elephant Vert. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Bio-based solutions are developed and distributed for sustainable agriculture.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lipofabrik

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Lipofabrik

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lipofabrik Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lipofabrik

Lipofabrik operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
CRISPR-engineered cell and gene therapies are developed for research applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lipofabrik

Frequently Asked Questions about Lipofabrik

When was Lipofabrik founded?

Lipofabrik was founded in 2013 and raised its 1st funding round 5 years after it was founded.

What does Lipofabrik do?

Lipofabrik is focussed on the production, purification, formulation and sales of biological and biodegradable molecules produced through bioprocesses based on renewable resources. Based on the research program developed at Probiogem laboratory, it is currently working on developing 6 different types of lipopeptides including Fengycin, Plipastatin, Iturin, Lichenysin, Mycosubtilin, Surfactin. It claims that these molecules possess physico-chemical properties and biological activities with the applications as emulsifier, surfactant, antimicrobial and plant systemic resistance inducer.

Who are the top competitors of Lipofabrik?

Lipofabrik's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Who are Lipofabrik's investors?

Lipofabrik has 2 investors. Key investors include European Union, and Groupe Elephant Vert.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available